Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer

NCT02761889 is registered in ClinicalTrials.gov with Fundacao Champalimaud as lead sponsor.

NCT NCT02761889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02761889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer
Lead sponsor
Fundacao Champalimaud
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2013
Completion date
December 30, 2025
Enrollment
444 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the prostate